Device Maker further expands upon the broadest product portfolio of treatment options for women suffering with Stress Urinary Incontinence.
Los Angeles, Calif.–(BUSINESS WIRE)–Caldera Medical, a medical device company that develops best-in-class surgical products for the treatment of Stress Urinary Incontinence, Pelvic Organ Prolapse, and Polyps announced the launch of Desara® TVez, an expansion to their Desara® Family of products.
“Staying true to our commitment of being surgeon and patient focused, Caldera Medical collaborated with dozens of leading surgeons to bring enhanced ease of use and patient safety to life in the form of Desara® TVez” commented Bryon Merade, CEO of Caldera Medical.
“To safely and effectively treat patients surgically with stress urinary incontinence, physicians require tools and implants that enhance control and simplify the procedure,” said Robert Harris, M.D., a leading Urogynecologist from Jackson, MS. “In my opinion, Desara® TVez’s unique design accomplishes both. As an advisor during the development process of Desara® TVez, I saw first-hand how Caldera Medical’s dedication to improving products through physician engagement advances the care of women with Stress Urinary Incontinence and other pelvic health disorders.”
About Caldera Medical
All of us at Caldera Medical feel deeply connected to serving women, we see it as our responsibility to remain steadfast in our commitment to our Mission of Improving the Quality of Life for Women! We are proud that surgeons worldwide place their trust in us to deliver the best products to treat their patients.
Caldera Medical forms close relationships with surgeons and continues to build the company around a principle of customer intimacy. In partnership with our surgeon customers, Caldera Medical has the largest humanitarian program of any women’s health company and is committed to treating one million women in underserved populations around the world by the year 2025.
Caldera Medical has been named by INC 5000 as one of the fastest growing private companies for three consecutive years.